MedTrace Logo

Use of High Sensitivity Cardiac Troponin in Ruling Out Emergency Patients with Acute Myocardial Injury and Infarction

NCT04280926 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-12-17

No results posted yet for this study

Summary

Examine the analytical and clinical performance of Atellica IM TnIH assay for the diagnosis and rule out of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication.

Conditions

  • Acute Myocardial Infarction
  • Acute Coronary Syndrome

Interventions

DIAGNOSTIC_TEST

Cardiac Troponin Testing

Fresh serum or lithium heparin plasma samples will be measured with the Atellica IM TnIH assay (Siemens Heatlhineers).

Sponsors & Collaborators

Principal Investigators

  • Fred S Apple, PhD · Hennepin Healthcare Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-13
Primary Completion
2021-10-13
Completion
2024-10-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04280926 on ClinicalTrials.gov